Tuberculosis Prevention

Treatment helps in preventing TB among those at high risk

Published in AIDS Weekly, June 27th, 2005

The drug isoniazid reduced the incidence of tuberculosis among HIV-infected miners in South Africa, a population at high risk of TB, according to a new study.

Lead author Alison D. Grant, MBBS, PhD, of the London School of Hygiene and Tropical Medicine, presented the findings of the study at a Journal of the American Medical Association media briefing on tuberculosis at the National Press Club. The study was published in the June 8, 2005, issue of JAMA, a theme issue on TB.

A major consequence of the HIV epidemic in developing countries is the increasing incidence of TB. The cornerstone of TB control programs is the World Health...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of AIDS Weekly

Source: AIDS Weekly (2005-06-27)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry